Showing results (41-50 of 466) with videos related to

Sort By:
Pageof 47
Blood Cancer Journal|September 3, 2016
Outcome with lenalidomide plus dexamethasone followed by early autologous stem cell transplantation in patients with newly diagnosed multiple myeloma on the ECOG-ACRIN E4A03 randomized clinical trial: long-term follow-upN Biran, S Jacobus, D H Vesole, et al.
Bone Marrow Transplantation|July 22, 1999
Beta2-microglobulin and bone marrow plasma cell involvement predict complete responders among patients undergoing blood cell transplantation for myelomaS V Rajkumar, R Fonseca, M Q Lacy, et al.
Leukemia|June 22, 2007
Impact of lenalidomide therapy on stem cell mobilization and engraftment post-peripheral blood stem cell transplantation in patients with newly diagnosed myelomaS Kumar, A Dispenzieri, M Q Lacy, et al.
Leukemia|January 30, 2004
Effect of thalidomide therapy on bone marrow angiogenesis in multiple myelomaS Kumar, T E Witzig, A Dispenzieri, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|August 24, 2000
Prognostic value of bone marrow angiogenesis in multiple myelomaS V Rajkumar, T Leong, P C Roche, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|June 1, 1993
Successful treatment of simultaneous pulmonary Pseudallescheria boydii and Aspergillus terreus infection with oral itraconazoleS L Goldberg, D J Geha, W F Marshall, et al.
Bone Marrow Transplantation|June 1, 2004
Prognostic value of bone marrow angiogenesis in patients with multiple myeloma undergoing high-dose therapyS Kumar, M A Gertz, A Dispenzieri, et al.
American Journal of Hematology|December 12, 1997
Multiple myeloma associated with diffuse osteosclerotic bone lesions: a clinical entity distinct from osteosclerotic myeloma (POEMS syndrome)M Q Lacy, M A Gertz, C A Hanson, et al.
American Journal of Hematology|October 1, 1990
Cytogenetic findings in 21 cases of peripheral T-cell lymphomaD J Inwards, T M Habermann, P M Banks, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 17, 2001
Eligibility for hematopoietic stem-cell transplantation for primary systemic amyloidosis is a favorable prognostic factor for survivalA Dispenzieri, M Q Lacy, R A Kyle, et al.
Pageof 47